Under the professional training and development collaboration, Shire will employ the NIBRT-GE Single Use Technology Centre of Excellence and Emerson manufacturing automation platform to cover all aspects of biopharma manufacturing.
While all Dunboyne-based employees will receive training, the National Institute for Bioprocessing and Research Training (NIBRT) will train 20 staff members on-site for a period of 12 months.
NIBRT spokesperson Alison Quinn told us employees – who will receive training for the duration of the commissioning, validation, and start-up of the Dunboyne site – will develop quality processes while at the institute.
“Training will cover all aspects of the biopharma manufacturing process, with a focus on cell culture, downstream processing, and bioanalytics,” she told us.
Shire’s employees will begin training in Q3, 2018.
Single-use at Dunboyne
Shire announced plans to construct the $400m biologics manufacturing facility in April, 2016.
A spokesperson told us the 120-acre campus will “adopt single use technology in the manufacturing processes, will be a highly automated facility and will also be the European Quality Control Hub for Shire’s biologics portfolio.”
The expansion – which will create approximately 400 jobs – responds to an increase in product demand, she added.